Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer

Autor: Thomas R. Cox, Paul Timpson, Lidia E. Leonte, Lukram Babloo Singh, Wolfgang Jarolimek, Joan Chang, Janine T. Erler, Morghan C. Lucas, Jonathan S. Foot, Mandar Deodhar, Marc Garcia-Montolio, Alison D. Findlay

Publikováno v: Chang, J, Lucas, M C, Leonte, L E, Garcia-Montolio, M, Singh, L B, Findlay, A D, Deodhar, M, Foot, J S, Jarolimek, W, Timpson, P, Erler, J T & Cox, T R 2017, ' Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer ', Oncotarget . https://doi.org/10.18632/oncotarget.15257
Chang, J, Lucas, M C, Leonte, L E, Garcia-Montolio, M, Singh, L B, Findlay, A D, Deodhar, M, Foot, J S, Jarolimek, W, Timpson, P, Erler, J T & Cox, T R 2017, ' Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer ', OncoTarget, vol. 8, no. 16, pp. 26066-26078 . https://doi.org/10.18632/oncotarget.15257
Oncotarget

// Joan Chang 1 , Morghan C. Lucas 2 , Lidia E. Leonte 1 , Marc Garcia-Montolio 1 , Lukram Babloo Singh 1 , Alison D. Findlay 3 , Mandar Deodhar 3 , Jonathan S. Foot 3 , Wolfgang Jarolimek 3 , Paul Timpson 2 , Janine T. Erler 1 , Thomas R. Cox 1, 2 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60d1ecaaf3616c775c04eb52cde9a905
https://doi.org/10.18632/oncotarget.15257